Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease

Tadeusz Osadnik1, Joanna Strzelczyk, Michał Hawranek

  • 1IIIrd Chair and Department of Cardiology, Silesian Centre for Heart Diseases, Medical University of Silesia in Katowice, Medical Faculty in Zabrze, Ul, Marii Skłodowskiej Curie 9, 41-800, Zabrze, Poland. tadeusz.osadnik@sccs.pl.

Insights

Higher red cell distribution width (RDW) values are linked to increased mortality in patients with stable coronary artery disease. RDW is an independent predictor of death in this population.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Hematology

Background:

  • Limited data exists on red cell distribution width (RDW) and mortality in stable coronary artery disease (CAD).
  • Percutaneous coronary intervention (PCI) is a common procedure for stable CAD patients.

Purpose of the Study:

  • To investigate the association between RDW values and mortality in patients with stable CAD undergoing PCI.
  • To determine if RDW is an independent predictor of mortality in this cohort.

Main Methods:

  • Analysis of 2550 stable CAD patients who underwent PCI.
  • Patients categorized into four groups based on RDW quartiles.
  • Cox proportional regression analysis adjusted for clinical, echocardiographic, hemodynamic, and laboratory data.

Main Results:

  • A stepwise relationship observed between RDW levels and comorbidities.
  • Highest RDW quartile associated with older age and increased burden of diabetes, heart failure, and chronic kidney disease.
  • Nearly four-fold increase in mortality observed between the lowest and highest RDW quartiles (4.3% vs. 17.1%).
  • Adjusted analysis confirmed RDW as a significant predictor of mortality (HR 1.23).

Conclusions:

  • Elevated RDW values correlate with higher comorbidity and mortality rates.
  • RDW is an independent predictor of mortality in patients with stable coronary artery disease.
  • RDW may serve as a valuable prognostic marker in stable CAD patients post-PCI.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952